CDEK
← All drugs Report issue

lbl-007

mAbexperimental

Clinical trial activity

9 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
8
Phase 3
0
Phase 4
0

Earliest trial started Dec 30, 2020 (NCT04640545)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2022

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07099430Phase 1/Phase 2 (Phase 2)Sep 5, 2025Fujian Medical University, Nanjing Leads Biolabs Co.,Ltd
NCT06010303Phase 2Nov 8, 2023BeOne Medicines
NCT05909904Phase 2Jul 21, 2023BeOne Medicines
NCT05635708Phase 2Mar 31, 2023BeOne Medicines
NCT05609370Phase 1/Phase 2 (Phase 2)Feb 28, 2023BeOne Medicines
NCT05577702Phase 2Dec 31, 2022BeOne Medicines
NCT05516914Phase 1/Phase 2 (Phase 2)Sep 1, 2022Nanjing Leads Biolabs Co.,Ltd, Sun Yat-Sen University
NCT05102006Phase 1/Phase 2 (Phase 2)Dec 22, 2021Nanjing Leads Biolabs Co.,Ltd, Sun Yat-Sen University
NCT04640545Phase 1Dec 30, 2020Chinese Academy of Medical Sciences, Nanjing Leads Biolabs Co.,Ltd
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
BeOne MedicinesFor profit5512022
Nanjing Leads Biolabs Co.,LtdFor profit4422020
Sun Yat-Sen UniversityAcademic/Hospital2012021
Chinese Academy of Medical SciencesAcademic/Hospital1012020
Fujian Medical UniversityAcademic/Hospital1012025
5 organizations
Page 1 / 1